Study to Understand Risk Information to Support and Empower

NCT05752292 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2026-05-12

No results posted yet for this study

Summary

The aim of this trial is to test components of a digital health outreach intervention to promote uptake of postpartum screening and lifestyle programs for diabetes prevention among patients with gestational diabetes (GDM). The outreach intervention, designed to be interactive and delivered online, includes standard health information plus up to four theory-based components, targeting motivational and logistical barriers to engaging in diabetes preventive care during the postpartum period. The trial leverages the Multiphase Optimization Strategy (MOST) using a randomized factorial study design.

Conditions

  • Diabetes, Gestational
  • Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Standard Health Information

Standard health information about postpartum screening and lifestyle programs for diabetes prevention

BEHAVIORAL

Values Affirmation (VA)

Interactive prompts to reflect on core personal values

BEHAVIORAL

Tailored Risk Information (TRI)

Interactive prompts to provide tailored information on risk factors for type 2 diabetes

BEHAVIORAL

Motivational Interviewing-based (MI)

Interactive prompts based on principles of motivational interviewing

BEHAVIORAL

Action planning (AP)

Interactive prompts to problem solve challenges

Sponsors & Collaborators

  • Kaiser Foundation Research Institute

    collaborator OTHER
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH
  • University of California, Davis

    lead OTHER

Principal Investigators

  • Susan D Brown, PhD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-13
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05752292 on ClinicalTrials.gov